Tremor News and Research

Latest Tremor News and Research

GLNT to use $1.5M NIH award to expand Parkinson’s monitoring technology to mobile apps

Great Lakes NeuroTechnologies announced today they will be using a $1.5M award from NIH to expand their Parkinson’s monitoring technology to mobile applications. Repositioning GLNT’s Kinesia product line with mobile apps strategically aligns with growing trends in domestic and international healthcare landscapes regarding accessibility, costs, reimbursement, and regulatory policies.

16 Apr 2014

Northwestern University awarded NIH grant to conduct phase III Parkinson's neuroprotective study

Tanya Simuni, M.D., medical director of Northwestern University's Parkinson's Disease and Movement Disorders Center, was awarded a grant from the National Institutes of Health to conduct a $16 million phase III study of the safety and efficacy of the drug isradipine as a potential neuroprotective agent in Parkinson's disease.

2 Apr 2014

GLNT receives allowance of patent for Parkinson's disease monitoring technology

Great Lakes NeuroTechnologies announced today they have received a new allowance of claims from the U.S. Patent Office, the company’s fourth in the past eight months focused on technology for Parkinson’s disease diagnostics and treatment.

5 Mar 2014

Researchers identify high levels of certain protein in brains of people suffering from essential tremor

A team of researchers from Universit- Laval and CHU de Qu-bec identified unusually high levels of a certain protein in the brains of people suffering from essential tremor (ET), a movement disorder that affects 4% of the adult population.

5 Mar 2014

Researchers develop new handheld electronic device that help overcome hand shakes caused by tremor

For people whose hands shake uncontrollably due to a medical condition, just eating can be a frustrating and embarrassing ordeal - enough to keep them from sharing a meal with others.

3 Mar 2014

Great Lakes NeuroTechnologies receives another patent for Parkinson’s disease monitoring technology

Great Lakes NeuroTechnologies announced today they have received another allowance of claims from the U.S. Patent Office. The application covers a system and method of controlling Parkinson's therapy in response to motor symptoms.

5 Feb 2014

Boston Scientific gets CE Mark approval for Vercise Deep Brain Stimulation System

The Boston Scientific Corporation Vercise Deep Brain Stimulation System has received CE Mark approval for the treatment of intractable primary and secondary dystonia, a neurological movement disorder characterized by involuntary muscle contractions.

19 Nov 2013

Screening for nonmotor symptoms in early Parkinson’s urged

Nonmotor symptoms have a substantial impact on the health-related quality of life of patients with early Parkinson’s disease, research shows.

14 Nov 2013

Researchers clinically validate new method for predicting Alzheimer's progression

A Columbia University Medical Center-led research team has clinically validated a new method for predicting time to full-time care, nursing home residence, or death for patients with Alzheimer's disease.

8 Nov 2013

Modeling, identifying predictors of Parkinson's disease with stem cells

The New York Stem Cell Foundation Research Institute has entered into a partnership with the Parkinson's Progression Markers Initiative to build resources for studying Parkinson's disease to accelerate new treatments. Sponsored by The Michael J. Fox Foundation for Parkinson's Research, PPMI is a landmark effort to identify and validate biomarkers of Parkinson's disease.

15 Oct 2013

Researcher to examine effect of getting older on people's ability to use smart phones

Age-related difficulties in texting and emailing on smart phones will be investigated by a University of Strathclyde academic.

11 Oct 2013

Study discovers biomarker that helps doctors to accurately diagnose Parkinson's at earlier stage

Although Parkinson's disease is the second most prevalent neurodegenerative disorder in the U.S., there are no standard clinical tests available to identify this widespread condition.

8 Oct 2013

Parkinsonism predicts schizophrenia cognitive course

Parkinsonism is common in patients with first-episode psychosis and is predictive of cognitive impairment, say researchers.

3 Oct 2013

Promising early findings from Parkinson’s biomarker study

Early results from the Parkinson’s Progression Markers Initiative suggest that some cerebrospinal fluid biomarkers hold diagnostic and prognostic promise.

18 Sep 2013

InSightec: First patient treated in ExAblate Neuro Phase III pivotal trial for tremor

InSightec Ltd, the global leader in MR guided focused ultrasound, announced that the first patient has been treated as part of an ExAblate Neuro Phase III pivotal trial. The trial is a multicenter, double-blinded, randomized study to evaluate the efficacy and safety of treatment using the ExAblate Neuro in medication-refractory essential tremor patients.

11 Sep 2013

GLNT integrates video conferencing technology into Kinesia HomeView for Parkinson’s disease patients

Great Lakes NeuroTechnologies announced today they are launching commercialization and clinical studies to expand their telemedicine technology, Kinesia HomeView, for individuals with Parkinson’s disease by adding real-time video conferencing.

7 Sep 2013

Stem cell researchers receive Early Translational research awards from CIRM

Four prominent researchers from UCLA's Eli & Edythe Broad Center of Regenerative Medicine and Stem Cell Research have received Early Translational research awards totaling approximately $13 million from the California Institute for Regenerative Medicine (CIRM) the state stem cell agency. The UCLA researchers received four of the 12 total awards; no other applicant institution received more than one award.

30 Aug 2013

Comprehensive test of biomarkers have prognostic and diagnostic value in Parkinson's disease

Perelman School of Medicine researchers at the University of Pennsylvania report the first biomarker results reported from the Parkinson's Progression Markers Initiative (PPMI), showing that a comprehensive test of protein biomarkers in spinal fluid have prognostic and diagnostic value in early stages of Parkinson's disease.

27 Aug 2013

Navidea Biopharmaceuticals signs SPA agreements with FDA for NAV5001 Phase 3 program

Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that it has reached agreement with the U.S. Food and Drug Administration for two special protocol assessments for the Company's pivotal Phase 3 program with NAV5001 as an aid in the differential diagnosis of Parkinsonian Syndromes from non-Parkinsonian tremor.

23 Aug 2013

UCSF study shows potential for new treatment strategy for Parkinson’s disease

UC San Francisco scientists working in the lab used a chemical found in an anti-wrinkle cream to prevent the death of nerve cells damaged by mutations that cause an inherited form of Parkinson-s disease.

17 Aug 2013

Tremor News and Research

Latest Tremor News and Research

GLNT to use $1.5M NIH award to expand Parkinson’s monitoring technology to mobile apps

Northwestern University awarded NIH grant to conduct phase III Parkinson's neuroprotective study

GLNT receives allowance of patent for Parkinson's disease monitoring technology

Researchers identify high levels of certain protein in brains of people suffering from essential tremor

Researchers develop new handheld electronic device that help overcome hand shakes caused by tremor

Great Lakes NeuroTechnologies receives another patent for Parkinson’s disease monitoring technology

Boston Scientific gets CE Mark approval for Vercise Deep Brain Stimulation System

Screening for nonmotor symptoms in early Parkinson’s urged

Researchers clinically validate new method for predicting Alzheimer's progression

Modeling, identifying predictors of Parkinson's disease with stem cells

Researcher to examine effect of getting older on people's ability to use smart phones

Study discovers biomarker that helps doctors to accurately diagnose Parkinson's at earlier stage

Parkinsonism predicts schizophrenia cognitive course

Promising early findings from Parkinson’s biomarker study

InSightec: First patient treated in ExAblate Neuro Phase III pivotal trial for tremor

GLNT integrates video conferencing technology into Kinesia HomeView for Parkinson’s disease patients

Stem cell researchers receive Early Translational research awards from CIRM

Comprehensive test of biomarkers have prognostic and diagnostic value in Parkinson's disease

Navidea Biopharmaceuticals signs SPA agreements with FDA for NAV5001 Phase 3 program

UCSF study shows potential for new treatment strategy for Parkinson’s disease

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Tremor News and Research

Latest Tremor News and Research

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Newsletters you may be interested in